National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 7) (No. PB 94 of 2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L02284

 
PB 94 of 2012
National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 7)1
National Health Act 1953
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 26 November 2012
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2012 (No. 7).
            (2)        This Instrument may also be cited as PB 94 of 2012.
2          Commencement
            This Instrument commences on 1 December 2012.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1]      Schedule 1, entry for Atenolol
omit from the column headed “Claimed Price”:          3.72        substitute:             4.24
[2]      Schedule 1, entry for Betamethasone
omit:
 
Ointment 200 micrograms (as valerate) per g, 100 g
Application
Celestone-M
1
7.20
8.19
[3]      Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)
(a)           omit from the column headed “Determined Price”:     2.06        substitute:             2.83
(b)           omit from the column headed “Claimed Price”:          3.64        substitute:             4.41
[4]      Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)
(a)           omit from the column headed “Determined Price”:     2.41        substitute:             2.94
(b)           omit from the column headed “Claimed Price”:          3.99        substitute:             4.51
[5]      Schedule 1, entry for Escitalopram in the form Tablet 10 mg (as oxalate)
omit from the column headed “Claimed Price”:          9.87        substitute:             11.26
[6]      Schedule 1, entry for Escitalopram in the form Tablet 20 mg (as oxalate)
omit from the column headed “Claimed Price”:          11.04     substitute:             13.08
[7]      Schedule 1, entry for Indapamide
omit from the column headed “Claimed Price”:          8.79        substitute:             10.46
 
[8]      Schedule 1, entry for Isosorbide Mononitrate
substitute:
Isosorbide Mononitrate
Tablet 60 mg (sustained release)
Oral
Imdur Durule
30
4.45
7.48

 
 
 
Monodur 60 mg
30
4.45
6.67

 
Tablet 120 mg (sustained release)
Oral
Imdur 120 mg
30
10.54
13.57

[9]      Schedule 1, entry for Lisinopril in the form Tablet 5 mg [Zestril]
omit from the column headed “Claimed Price”:          5.61        substitute:             7.45
[10]    Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Zestril]
omit from the column headed “Claimed Price”:          7.82        substitute:             9.66
[11]    Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Zestril]
omit from the column headed “Claimed Price”:          9.54        substitute:             11.38
[12]    Schedule 1, entry for Loperamide
(a)           omit from the column headed “Determined Price”:     1.65        substitute:             1.39
(b)           omit from the column headed “Claimed Price”:          2.37        substitute:             1.99
[13]    Schedule 1, entry for Meloxicam
substitute:
Meloxicam
Capsule 7.5 mg
Oral
Mobic
30
6.82
8.24

 
Capsule 15 mg
Oral
Mobic
30
9.95
11.37

 
Tablet 7.5 mg
Oral
Mobic
30
6.82
8.24

 
Tablet 15 mg
Oral
Mobic
30
9.95
11.37

[14]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Betaloc]
omit from the column headed “Claimed Price”:          4.78        substitute:             5.79
 
[15]    Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Betaloc]
omit from the column headed “Claimed Price”:          5.53        substitute:             6.55
[16]    Schedule 1, entry for Mirtazapine
substitute:
Mirtazapine
Tablet 15 mg (orally disintegrating)
Oral
Avanza SolTab
30
13.75
14.72

 
Tablet 30 mg
Oral
Avanza
30
11.96
14.79

 
Tablet 30 mg (orally disintegrating)
Oral
Avanza SolTab
30
18.34
19.32

 
Tablet 45 mg
Oral
Avanza
30
19.95
22.79

 
Tablet 45 mg (orally disintegrating)
Oral
Avanza SolTab
30
27.64
28.72

[17]    Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g
omit from the column headed “Claimed Price”:          8.05        substitute:             8.85
[18]    Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL
omit from the column headed “Claimed Price”:          11.53     substitute:             12.34
[19]    Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g
omit from the column headed “Claimed Price”:          8.05        substitute:             8.85
[20]    Schedule 1, entry for Omeprazole
omit from the column headed “Claimed Price”:          12.82     substitute:             14.17
[21]    Schedule 1, entry for Prochlorperazine
omit from the column headed “Claimed Price”:          3.92        substitute:             4.62
[22]    Schedule 1, entry for Propranol in the form Tablet containing propranol hydrochloride 10 mg
omit from the column headed “Claimed Price”:          5.59        substitute:             6.08
[23]    Schedule 1, entry for Propranol in the form Tablet containing propranol hydrochloride 40 mg
omit from the column headed “Claimed Price”:          5.89        substitute:             6.38
[24]    Schedule 1, entry for Telmisartan in the form Tablet 40 mg
omit from the column headed “Claimed Price”:          7.89        substitute:             8.29
[25]    Schedule 1, entry for Telmisartan in the form Tablet 80 mg
omit from the column headed “Claimed Price”:          19.80     substitute:             20.21
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.
Read Entire Law on www.comlaw.gov.au